XML 34 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
Collaborative Arrangements (Tables)
6 Months Ended
Jun. 30, 2012
Collaborative Arrangements  
Revenues related to collaborative arrangements

 

        

 
  Three Months Ended
June 30,
  Six Months Ended
June 30,
 
 
  2012   2011   2012   2011  
 
  (in thousands)
 

Royalty revenues

  $ 27,970   $ 2,549   $ 60,854   $ 2,549  
                   

Collaborative revenues:

                         

Amortized portion of up-front payment

  $ 3,107   $ 3,107   $ 6,214   $ 6,214  

Milestone revenues

                50,000  

Net payment for telaprevir development costs

    (927 )   (3,108 )   (2,066 )   (4,253 )

Reimbursement for manufacturing services

        9,059     4,449     13,213  
                   

Total collaborative revenues attributable to the Janssen collaboration

  $ 2,180   $ 9,058   $ 8,597   $ 65,174  
                   

Total revenues attributable to the Janssen collaboration

  $ 30,150   $ 11,607   $ 69,451   $ 67,723  
                   

 

 

      

 
  Three Months Ended June 30,   Six Months Ended June 30,  
 
  2012   2011   2012   2011  
 
  (in thousands)
 

Amortized portion of up-front payments

  $ 3,186   $ 9,558   $ 12,744   $ 19,116  

Milestone revenues

        182     485     1,394  

Payments for manufacturing services

    1,659     5,133     5,650     5,848  
                   

Total collaborative revenues attributable to the Mitsubishi Tanabe collaboration

  $ 4,845   $ 14,873   $ 18,879   $ 26,358  
                   
Summary of activity related to net income (loss) attributable to noncontrolling interest (Alios)

 

 

 
  Three Months Ended
June 30,
  Six Months Ended
June 30,
 
 
  2012   2011   2012   2011  
 
  (in thousands)
 

Loss before provision for income taxes

  $ (4,467 ) $ (801 ) $ (9,491 ) $ (801 )

Change in fair value of contingent milestone and royalty payments

    56,170         55,200      

Provision for income taxes

    (21,240 )   (24,448 )   (18,960 )   (24,448 )
                   

Net income (loss) attributable to noncontrolling interest (Alios)

  $ 30,463   $ (25,249 ) $ 26,749   $ (25,249 )
                   
Summary of Alios' items included in the Company's consolidated balance sheets

 

 

 
  As of June 30, 2012   As of December 31, 2011  
 
  (in thousands)
 

Restricted cash and cash equivalents (Alios)

  $ 56,024   $ 51,878  

Prepaid expenses and other current assets

    1,952     2,299  

Property and equipment, net

    1,820     1,925  

Intangible assets

    250,600     250,600  

Goodwill

    4,890     4,890  

Other assets

    145     133  

Accounts payable

    1,686     4,132  

Accrued expenses and other current liabilities

    5,647     4,291  

Accrued interest

    13     13  

Income taxes payable (Alios)

    201     12,075  

Deferred tax liability

    135,431     116,121  

Other liabilities

    762     1,030  

Redeemable noncontrolling interest (Alios)

    37,914     37,036  

Noncontrolling interest (Alios)

    167,920     141,633